DOYLESTOWN, Pa., Aug. 16, 2017 -- Alamo Pharma Services, an established leader in attracting exceptional talent in the pharmaceutical and biotech industries, has formed a specialized division of the company that offers partner organizations recruiting services to place the right people with the right attitude and the right talent in the right position within the client company.
|
||||||||
“The investment companies make in bringing products to market is not fully realized until they put that product in the best position to be promoted to healthcare providers,” says Amy Peek, Alamo’s Executive Director, Talent Management and Growth. “Alamo can help in all aspects of recruitment to ensure that our clients have the representatives and sales leaders they need to increase sales and maximize their brand’s opportunity.”
Alamo’s recruiting experts work side by side with clients to provide a thoughtful, customized approach that follows behavioral models to ensure that the new hire is a perfect fit for both the job and company’s culture. Like any true partner, Alamo Recruitment Services stays integrally involved in the onboarding of new talent – a key step in boosting profitability and escalating growth.
“The foundation of pharmaceutical and biotech commercial organizations is its sales team,” says Peter Marchesini, Alamo Chief Operating Officer. “Establishing a best-in-class talent acquisition process ensures that you are getting the best possible person for your sales team. Alamo has an exceptional group of recruiting professionals in place who understand and embrace the challenges of today’s market. They are acutely knowledgeable about the pharmaceutical sales industry to better ensure successful results, not only to fill a role but for long-term success.”
Companies seeking a customized talent acquisition organization to attract and retain exceptional talent in the consistently changing pharmaceutical and biotech industries are encouraged to contact Alamo Recruitment Services via email at [email protected].
About Alamo Pharma Services
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit AlamoPharmaServices.com or email [email protected].
Alamo is a part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of outside companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/410950d3-5bb5-45f6-a201-919dd23293ce
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b2bab804-58fa-4995-bdc8-205903e97bba
Drew Deeter Alamo Pharma Services 215.348.3890 [email protected]


Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 



